Tower Research Capital (TRC)’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-5,465
| Closed | -$54.9K | – | 6299 |
|
|
2023
Q4 | $54.9K | Sell |
5,465
-28,969
| -84% | -$291K | ﹤0.01% | 3067 |
|
|
2023
Q3 | $99.2K | Buy |
34,434
+23,417
| +213% | +$67.4K | ﹤0.01% | 1985 |
|
|
2023
Q2 | $42K | Buy |
11,017
+3,352
| +44% | +$12.8K | ﹤0.01% | 2708 |
|
|
2023
Q1 | $14K | Sell |
7,665
-5,860
| -43% | -$10.7K | ﹤0.01% | 3934 |
|
|
2022
Q4 | $31K | Buy |
13,525
+5,168
| +62% | +$11.8K | ﹤0.01% | 2732 |
|
|
2022
Q3 | $27K | Buy |
8,357
+7,751
| +1,279% | +$25K | ﹤0.01% | 3705 |
|
|
2022
Q2 | $3K | Sell |
606
-1,548
| -72% | -$7.66K | ﹤0.01% | 5443 |
|
|
2022
Q1 | $5K | Sell |
2,154
-199
| -8% | -$462 | ﹤0.01% | 5137 |
|
|
2021
Q4 | $14K | Buy |
+2,353
| New | +$14K | ﹤0.01% | 4128 |
|